机器人辅助部分肾切除术的早期手术结局与肿瘤学结果:一项多中心研究
这项多中心研究分析了2012-2015年英格兰北部四家三级转诊中心连续接受机器人辅助部分肾切除术(RAPN)的250例患者,中位随访12个月。结果显示总体并发症率16.4%,切缘阳性率7.3%,68.4%达到「三连胜」(热缺血时间<25分钟、切缘阴性且无围手术期并发症),作者认为RAPN安全、并发症少,早期肿瘤学与肾功能保留结果令人鼓舞。
要点
- 250例RAPN中,总体并发症率16.4%,Clavien III级占6%,无Clavien IV/V级并发症。
- 切缘阳性率7.3%,82.4%肿瘤为恶性;68.4%患者达到「三连胜」。
- 术后估算肾小球滤过率较术前下降(80.8 vs 92.8 mL/min/1.73 m2,P=0.001),66%患者术后慢性肾脏病分期不变。
核心结论
- 作者认为这是英国最大的多中心RAPN研究,初步结果表明RAPN安全且可在低并发症率下实施,早期肿瘤学结局与肾功能保留数据令人鼓舞。
研究设计与样本
- 多中心研究,纳入2012-2015年英格兰北部四家三级转诊中心所有连续接受RAPN的患者,采用经腹腔途径标准化技术,前瞻性收集数据,使用单因素和多因素分析评估热缺血时间、切缘阳性率、并发症率、R.E.N.A.L.肾肿瘤评分与学习曲线之间的相关性。
- 共纳入250例患者,平均年龄58.1±13岁,平均体重指数27.3±7 kg/m2,中位随访12(范围3-36)个月。
主要发现
- 平均肿瘤大小30.6±10 mm,平均R.E.N.A.L.肾肿瘤评分6.1±2,55%肿瘤位于左侧。
- 平均手术控制台时间141±38分钟,热缺血时间16.7±8分钟,估计失血量205±145 mL;5例(2%)中转开放或根治性肾切除术。
- 总体并发症率16.4%(Clavien I级1.6%,Clavien II级8.8%,Clavien III级6%,Clavien IV/V级0%)。
- 病理结果显示82.4%肿瘤为恶性,总体切缘阳性率7.3%。
- 术前与术后即刻平均估算肾小球滤过率分别为92.8±27与80.8±27 mL/min/1.73 m2(P=0.001);66%患者术后慢性肾脏病分期不变,研究期间无患者需要透析。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe a multicentre experience of robot-assisted partial nephrectomy (RAPN) in northern England, with focus on early surgical outcomes and oncological results. PATIENTS AND METHODS: All consecutive patients undergoing RAPN at four tertiary referral centres in northern England in the period 2012-2015 were included for analysis. RAPN was performed via a transperitoneal approach using a standardized technique. Prospective data collection was performed to capture preoperative characteristics (including R.E.N.A.L. nephrometry score), and peri-operative and postoperative data, including renal function. Correlations between warm ischaemia time (WIT), positive surgical margin (PSM) rate, complication rates, R.E.N.A.L. nephrometry scores and learning curve were assessed using univariate and multivariate analyses. RESULTS: A total of 250 patients (mean age 58.1 ± 13 years, mean ± sd body mass index 27.3 ± 7 kg/m2 ) were included, with a median (range) follow-up of 12 (3-36) months. The mean ± sd tumour size was 30.6 ± 10 mm, mean R.E.N.A.L. nephrometry score was 6.1 ± 2 and 55% of tumours were left-sided. Mean ± sd operating console time was 141 ± 38 min, WIT 16.7 ± 8 min and estimated blood loss 205 ± 145 mL. There were five conversions (2%) to open/radical nephrectomy. The overall complication rate was 16.4% (Clavien I, 1.6%; Clavien II, 8.8%; Clavien III, 6%; Clavien IV/V; 0%). Pathologically, 82.4% of tumours were malignant and the overall PSM rate was 7.3%. The mean ± sd preoperative and immediate postoperative estimated glomerular filtration rates were 92.8 ± 27 and 80.8 ± 27 mL/min/1.73 m2 , respectively (P = 0.001). In all, 66% of patients remained in the same chronic kidney disease category postoperatively, and none of the patients required dialysis during the study period. 'Trifecta' (defined as WIT < 25 min, negative surgical margin status and no peri-operative complications) was achieved in 68.4% of patients overall, but improved with surgeon experience. PSM status and long WIT were significantly associated with early learning curve. CONCLUSION: This is the largest multicentre RAPN study in the UK. Initial results show that RAPN is safe and can be performed with minimal morbidity. Early oncological outcomes and renal function preservation data are encouraging.
引用
- Veeratterapillay R, Addla SK, Jelley C, et al. Early surgical outcomes and oncological results of robot-assisted partial nephrectomy: a multicentre study. BJU Int. 2017. PMID: 27988978. doi:10.1111/bju.13743
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。